Acute respiratory distress syndrome (ARDS) is a common clinical severe disease with strong heterogeneity and high mortality. At present, the diagnosis is mainly based on the Berlin definition, with poor sensitivity and specificity. We hope to find appropriate biomarkers to improve its diagnostic sensitivity and specificity.